Ticker >

Procter&Gamble Healt share price

Procter & Gamble Health Ltd.

NSE: PGHL BSE: 500126 SECTOR: Pharmaceuticals & Drugs  73k   347   37

5086.50
+0.20 (0.00%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 5133.05

Today's Low

₹ 5082.95

52 Week High

₹ 5640

52 Week Low

₹ 4487.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8443.28 Cr.

Enterprise Value

8003.06 Cr.

No. of Shares

1.66 Cr.

P/E

37.25

P/B

10.48

Face Value

₹ 10

Div. Yield

1.87 %

Book Value (TTM)

₹  485.49

CASH

440.22 Cr.

DEBT

0 Cr.

Promoter Holding

51.82 %

EPS (TTM)

₹  136.54

Sales Growth

10.34%

ROE

33.94 %

ROCE

46.07%

Profit Growth

19.19 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Procter & Gamble Health Ltd.

Seven seas evion nasvision Polybion Livogen Neurobion

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.34%
3 Year-3.21%
5 Year11.99%

Profit Growth

1 Year19.19%
3 Year-3.34%
5 Year19.56%

ROE%

1 Year33.94%
3 Year28.46%
5 Year23.03%

ROCE %

1 Year46.07%
3 Year37.86%
5 Year31.3%

Debt/Equity

0

Price to Cash Flow

35.78

Interest Cover Ratio

409.051948051948

CFO/PAT (5 Yr. Avg.)

0.793790134190926

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 51.82 0
Sep 2023 51.82 0
Jun 2023 51.82 0
Mar 2023 51.82 0
Dec 2022 51.82 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 28.4646754447902% over the past 3 years.
  • Company has been maintaining healthy ROCE of 37.8645625702533% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 409.051948051948.
  • The Company has been maintaining an effective average operating margins of 22.3442875199994% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -144.612691005287 days.
  • The company has a high promoter holding of 51.82%.

 Limitations

  • The company has shown a poor profit growth of -3.33888251834568% for the Past 3 years.
  • The company has shown a poor revenue growth of -3.20516925184755% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 309.97 320.92 301.18 304.93 309.97
Total Expenditure 201.11 241.26 255.84 216.27 208.32
Operating Profit 108.86 79.66 45.34 88.66 101.65
Other Income 4.54 4.97 5.46 6.05 5.18
Interest 0.23 0.21 0.17 0.18 0.19
Depreciation 8.23 5.89 6.5 6.48 6.92
Exceptional Items 0 0 0 0 0
Profit Before Tax 104.94 78.53 44.13 88.05 99.72
Tax 28.14 19.34 14.31 22.48 27.65
Profit After Tax 76.8 59.19 29.82 65.57 72.07
Adjusted EPS (Rs) 46.27 35.66 17.96 39.5 43.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Dec 2018 Jun 2020 Jun 2021 Jun 2022 Jun 2023
Net Sales 848.99 1355.86 1008.73 1114.41 1229.62
Total Expenditure 704.85 1041.52 762.71 846.73 904.94
Operating Profit 144.14 314.34 246.02 267.68 324.68
Other Income 28.4 69.96 18.1 13.19 18.39
Interest 0 0 0.8 0.42 0.77
Depreciation 21.12 29.45 30.04 27.08 28.1
Exceptional Items 6.56 0 0 0 0
Profit Before Tax 157.98 354.85 233.28 253.37 314.2
Tax 56.24 100.77 56.48 60.85 84.73
Net Profit 838.72 254.08 176.8 192.52 229.47
Adjusted EPS (Rs.) 61.29 153.06 106.51 115.98 138.23

Balance Sheet (All Figures are in Crores.)

Particulars Dec 2018 Jun 2020 Jun 2021 Jun 2022 Jun 2023
Equity and Liabilities
Share Capital 16.6 16.6 16.6 16.6 16.6
Total Reserves 1523.51 889.74 687.11 599.89 734.29
Borrowings 0 0 0 0 0
Other N/C liabilities 494.83 667.16 723.42 713.63 803
Current liabilities 547.69 538.62 550.68 607.73 679.08
Total Liabilities 2582.63 2112.12 1977.81 1937.85 2232.97
Assets
Net Block 99.76 97.92 100.96 109.06 141.72
Capital WIP 17.35 21.45 39.15 40.6 32.49
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 572.52 724.61 795.9 801.72 885.23
Other N/C Assets 3.82 3.3 2.95 2.6 2.25
Current Assets 1889.18 1264.84 1038.85 983.87 1171.28
Total Assets 2582.63 2112.12 1977.81 1937.85 2232.97
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Dec 2018 Jun 2020 Jun 2021 Jun 2022 Jun 2023
Profit from operations 1137.57 354.85 233.28 253.37 314.2
Adjustment -913.68 -12.16 40.89 27.31 41.49
Changes in Assets & Liabilities -50.26 -5.73 41.22 -47.3 -30.03
Tax Paid -304.02 -101.59 -68.13 -63.86 -89.66
Operating Cash Flow -130.39 235.37 247.26 169.52 236
Investing Cash Flow 1269.72 164.64 -32.27 -25.54 -21.5
Financing Cash Flow -30.12 -883.41 -386.63 -288.63 -98.47
Net Cash Flow 1109.21 -483.4 -171.64 -144.65 116.03

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 51.82 51.82 51.82 51.82 51.82
procter and gamble overse... 51.82 51.82 51.82 51.82 51.82
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 48.18 48.18 48.18 48.18 48.18
hdfc small cap fund - - 2.04 - 2.05
investor education and pr... 0.33 - - - 0.36
lici asm non par - - - 2.41 2.10
nippon life india trustee... - - - - 3.63
uti-mnc fund - - - - 1.27
hdfc mutual fund - hdfc s... - - - 2.04 -
investor education and pr... - 0.33 0.33 0.33 -
nippon life india trustee... 2.75 2.88 3.36 3.60 -
life insurance corporatio... 3.36 3.26 2.66 - -
hdfc trustee co ltd a/c h... 2.01 2.00 - - -
the new india assurance c... 1.00 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ2FY20 9 Jan 2020

Company News

Procter & Gamble Health informs about corporate action6 Feb 2024, 5:29PM Procter&Gamble Healt - Quaterly Results6 Feb 2024, 4:44PM Procter&Gamble Healt - Quaterly Results6 Feb 2024, 4:44PM Procter&Gamble Healt - Quaterly Results6 Feb 2024, 4:44PM Procter & Gamble Health informs about loss of share certificates20 Jan 2024, 1:13PM Procter & Gamble Health informs about loss of share certificate21 Dec 2023, 4:39PM Procter & Gamble Health informs about loss of share certificate 18 Dec 2023, 12:17PM Procter&Gamble Healt - Quaterly Results3 Nov 2023, 7:54PM Procter&Gamble Healt - Quaterly Results3 Nov 2023, 7:54PM Procter & Gamble Hygiene & Health Care informs about outcome of board meeting30 Oct 2023, 5:25PM Procter & Gamble Health informs about loss of share certificates21 Oct 2023, 10:34AM Procter & Gamble Health informs about disclosure 27 Sep 2023, 12:35PM Procter & Gamble Health to discontinue production of injections at Goa plant 27 Sep 2023, 10:50AM Procter&Gamble Healt - Quaterly Results23 Aug 2023, 8:31PM Procter&Gamble Healt - Quaterly Results23 Aug 2023, 8:31PM Procter & Gamble Health informs about issuance of duplicate share certificate27 Jul 2023, 9:02AM Procter & Gamble Health reports 16% rise in Q3 net profit16 May 2023, 11:13AM Procter&Gamble Healt - Quaterly Results15 May 2023, 8:16PM Procter&Gamble Healt - Quaterly Results15 May 2023, 8:16PM Procter & Gamble Health informs about resignation of executive director cum CFO17 Mar 2023, 1:05PM Procter & Gamble Health informs about resignation of director17 Mar 2023, 12:37PM Procter & Gamble Health informs about transcript of related party transactions20 Feb 2023, 4:46PM Procter & Gamble Health informs about loss of share certificate16 Feb 2023, 4:24PM Procter&Gamble Healt - Quaterly Results5 Feb 2023, 1:07PM Procter&Gamble Healt - Quaterly Results5 Feb 2023, 1:07PM Procter & Gamble Health informs about loss of share certificate28 Jan 2023, 12:43PM Procter & Gamble Health informs about details of loss of certificate 29 Nov 2022, 4:54PM Procter&Gamble Healt - Quaterly Results11 Nov 2022, 7:35PM Procter&Gamble Healt - Quaterly Results11 Nov 2022, 7:35PM Procter & Gamble Hygiene and Health Care informs about loss of share certificate 4 Nov 2022, 10:08AM Procter & Gamble Health informs about annual report1 Nov 2022, 11:49AM Procter & Gamble Health informs about issuance of duplicate share certificate17 Sep 2022, 9:56AM Procter & Gamble Health informs about outcome of board meeting29 Aug 2022, 4:23PM Procter&Gamble Healt - Quaterly Results29 Aug 2022, 3:16PM Procter&Gamble Healt - Quaterly Results29 Aug 2022, 3:16PM Procter&Gamble Healt - Quaterly Results29 Aug 2022, 3:16PM Procter & Gamble Health informs about annual secretarial compliance report29 Aug 2022, 12:11PM Procter & Gamble Health partners with Lakshya and Recycle India Foundation6 Jun 2022, 4:59PM Procter&Gamble Healt - Quaterly Results5 May 2022, 7:39PM Procter&Gamble Healt - Quaterly Results5 May 2022, 7:39PM Procter&Gamble Healt - Quaterly Results9 Feb 2022, 1:13PM Procter&Gamble Healt - Quaterly Results9 Feb 2022, 1:13PM Procter&Gamble Healt - Quaterly Results9 Feb 2022, 1:13PM Procter & Gamble Health informs about resignation and appointment of non-executive director25 Sep 2021, 10:24AM Procter & Gamble Health informs about 54th AGM 18 Sep 2021, 4:55PM Procter & Gamble Health informs about revised intimation regarding appointment of CS 27 Aug 2021, 12:14PM Procter & Gamble Health informs about change in directorate27 Aug 2021, 10:25AM Procter & Gamble Health informs about board meeting 16 Aug 2021, 5:29PM Procter & Gamble Health informs about compliance certificate8 Jul 2021, 4:53PM Procter & Gamble Health board to consider unaudited financial results27 Apr 2021, 4:56PM

Procter&Gamble Healt Stock Price Analysis and Quick Research Report. Is Procter&Gamble Healt an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Procter&Gamble Healt and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Procter&Gamble Healt cash from the operating activity was Rs 236 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Procter&Gamble Healt has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Procter&Gamble Healt , the EPS growth was 19.1927805690665 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Procter&Gamble Healt has OPM of 26.4049055805859 % which is a good sign for profitability.
     
  • ROE: Procter&Gamble Healt have a healthy ROE of 33.9387395914987 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Procter&Gamble Healt is Rs 5091.05. One can use valuation calculators of ticker to know if Procter&Gamble Healt share price is undervalued or overvalued.
Last Updated on:
Brief about Procter&Gamble Healt

Procter & Gamble Health Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Procter & Gamble Health Ltd. stock analysis page is a comprehensive resource for long-term investors searching for accurate information about the company. Our website provides investors with necessary tools and resources, including share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders analysis. These tools enable investors to make informed investment decisions that ensure long-term growth.

Procter & Gamble Health Ltd. Share Price Analysis:

Procter & Gamble Health Ltd.'s share price is a key indicator of the company's financial performance. As a potential investor, it's crucial to analyze the share price's trends and performance over time. Our stock analysis page provides investors with historical share price charts that track the company's performance over an extended period. This feature allows investors to monitor the stock's performance and identify trends that may impact future growth. Our pre-built screening tools can assist investors in comparing Procter & Gamble Health Ltd.'s share price performance with its peers, enabling them to make informed investment decisions. A stock's share price is determined by a range of factors such as market sentiment, financial performance, and general economic conditions. 

Procter & Gamble Health Ltd. Balance Sheet Analysis:

Analyzing Procter & Gamble Health Ltd.'s balance sheet is an essential factor for investors interested in understanding the company's financial stability and health. The balance sheet's information provides important insights into the company's assets, liabilities, and shareholders' equity. Our website provides access to Procter & Gamble Health Ltd.'s balance sheet as a downloadable document, which investors can use to perform an in-depth analysis. In addition, our pre-built screening tools can assist investors in analyzing the company's financial health and evaluating its long-term growth potential.

Procter & Gamble Health Ltd. Annual Report Analysis:

Procter & Gamble Health Ltd.'s annual report is a vital resource for investors interested in long-term investments. The report offers information on the company's strategic initiatives, future goals, and financial performance. Our website offers investors access to the company's annual report as a downloadable document that they can use to perform an in-depth analysis. Our pre-built screening tools can also provide insights into the company's performance, making it easier for investors to make informed investment decisions.

Procter & Gamble Health Ltd. Dividend Analysis:

Investors interested in Procter & Gamble Health Ltd.'s stock should evaluate the company's dividend payout policies. The company's dividend payout trends are a crucial factor when assessing the stock's potential for long-term growth. Our website features information on the company's dividend payout history, providing investors with valuable insights into the company's potential as a long-term investment option.

Procter & Gamble Health Ltd. Quarterly Results Analysis:

Procter & Gamble Health Ltd.'s quarterly results offer insights into the company's financial performance, including revenue, profit, and loss. Investors can use this information to assess the company's growth potential. Our website features a downloadable copy of Procter & Gamble Health Ltd.'s quarterly results, which investors can use to make informed investment decisions. Our pre-built screening tools provide insights into the company's financial performance compared to its peers, allowing investors to evaluate its long-term growth potential.

Procter & Gamble Health Ltd. Stock Price Analysis:

Monitoring Procter & Gamble Health Ltd.'s stock prices regularly is crucial when assessing the company's financial performance. Our stock analysis page features current stock price updates, enabling investors to track market trends and identify potential investment opportunities. Our pre-built screening tools can also help investors analyze the company's stock price performance compared to its peers, making it easier to make informed investment decisions. Our website provides pre-built screening tools to help investors analyze stock price and performance.

Procter & Gamble Health Ltd. Price Chart Analysis:

A visual representation of Procter & Gamble Health Ltd.'s share price trends over time is a valuable tool for long-term investors. The price chart allows investors to analyze the company's share price performance and identify any trends that could impact future growth. Our website provides investors with a price chart they can use for an in-depth analysis. Our pre-built screening tools can also assist investors in evaluating the company's long-term growth potential by analyzing its performance compared to its peers.

Procter & Gamble Health Ltd. News Analysis:

Keeping up with the latest news and developments that impact Procter & Gamble Health Ltd.'s stock is crucial for investors. Our website offers timely news articles related to the company, providing investors with up-to-date insights into its performance. The news section of our website features reliable information on significant events, regulatory changes, and other factors that could potentially impact the stock's performance. Our pre-built screening tools can also provide investors with information about the company's global and local news.

Procter & Gamble Health Ltd. Concall Transcripts Analysis:

Procter & Gamble Health Ltd.'s concall transcripts offer investors insights into the company's future guidance and outlook. Our website provides access to these critical documents, enabling long-term investors to stay informed about the company's financial health and future growth. Our pre-built screening tools can also help investors perform an in-depth analysis of the information presented in the transcripts.

Procter & Gamble Health Ltd. Investor Presentations Analysis:

Procter & Gamble Health Ltd. prepares investor presentations to offer investors detailed information on the company's operations and financial performance. These presentations are valuable resources for long-term investors to study the company's strategic initiatives, providing necessary insights that could potentially impact the stock's value. Our website offers access to these presentations as downloadable documents that investors can use for an in-depth analysis. Our premium feature tools can also assist investors in performing a comprehensive analysis of the presented data.

Procter & Gamble Health Ltd. Promoters and Shareholders Analysis:

Understanding Procter & Gamble Health Ltd.'s promoters and shareholders is essential when assessing the viability of investing in its stock. Our stock analysis page provides vital information regarding the company's promoters and other shareholders. Long-term investors must consider these elements before making any investment decisions. Our pre-built screening tools can assist investors in analyzing the company's shareholding patterns and evaluating its growth potential.

Read More
X